Desormais Iléana, Aboyans Victor, Pesteil Francis, Lacroix Philipe
Faculty of Medicine, Tropical Neuroepidemiology, Inserm UMR 1094, 2, rue du Docteur-Marcland, 87025 Limoges, France; CHU Dupuytren, service de chirurgie vasculaire et thoracique-médecine vasculaire, 2, avenue M.L.-King, 87042 Limoges cedex, France.
Faculty of Medicine, Tropical Neuroepidemiology, Inserm UMR 1094, 2, rue du Docteur-Marcland, 87025 Limoges, France; CHU Dupuytren, service de cardiologie, 2, avenue M.L.-King, 87042 Limoges cedex, France.
Presse Med. 2018 Jan;47(1):56-61. doi: 10.1016/j.lpm.2017.09.019. Epub 2017 Dec 19.
Medical management of peripheral arterial disease (PAD) patients is aimed at limb symptom relief and reducing systemic major adverse events risk. For the first purpose: exercise therapy is recommended in case of claudication; multidisciplinary evaluation for surgical options is mandatory in case of critical limb ischaemia. Reducing cardiac and stroke risk can be achieved through: statin prescription in most of the cases; antiplatelet agents in symptomatic PAD patients; cardio-vascular risk factors control.
外周动脉疾病(PAD)患者的药物治疗旨在缓解肢体症状并降低全身性主要不良事件的风险。对于第一个目的:跛行患者建议进行运动疗法;严重肢体缺血患者必须进行多学科评估以确定手术方案。降低心脏和中风风险可通过以下方式实现:大多数情况下使用他汀类药物;有症状的PAD患者使用抗血小板药物;控制心血管危险因素。